ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPPL2 | Alkaline phosphatase, placental-like 2 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMOT | Angiomotin | Predicted intracellular proteins
| | | | | Tissue enhanced |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APLN | Apelin | Predicted intracellular proteins
| | | | | Tissue enhanced |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AREG | Amphiregulin | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ARTN | Artemin | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BIRC7 | Baculoviral IAP repeat containing 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BMP1 | Bone morphogenetic protein 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
BMP5 | Bone morphogenetic protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BMP6 | Bone morphogenetic protein 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
BMP7 | Bone morphogenetic protein 7 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C20orf202 | Chromosome 20 open reading frame 202 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2orf83 | Chromosome 2 open reading frame 83 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CD300LG | CD300 molecule-like family member g | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN6 | Claudin 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC1A | C-type lectin domain family 1, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CNTN5 | Contactin 5 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL11A1 | Collagen, type XI, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL15A1 | Collagen, type XV, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL21A1 | Collagen, type XXI, alpha 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL4A1 | Collagen, type IV, alpha 1 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL5A3 | Collagen, type V, alpha 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COLEC12 | Collectin sub-family member 12 | Predicted membrane proteins
| | | | | Tissue enhanced |
COX4I2 | Cytochrome c oxidase subunit IV isoform 2 (lung) | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CRLF1 | Cytokine receptor-like factor 1 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRYBB1 | Crystallin, beta B1 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYTL1 | Cytokine-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DACT2 | Dishevelled-binding antagonist of beta-catenin 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
DIO3 | Deiodinase, iodothyronine, type III | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |